期刊
FRONTIERS IN ONCOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2022.960527
关键词
rectal neoplasm; lateral pelvic lymph node; recurrence; lymph node dissection; neoadjuvant treatment; radiotherapy; chemoradiation
类别
资金
- Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education
- [NRF-2022R1C1C1005415]
Rectal cancer is a common malignancy worldwide. While total mesorectal excision (TME) and neoadjuvant chemoradiation (NCRT) have improved intrapelvic local control, lateral pelvic recurrence remains problematic, especially in patients with clinically suspicious lateral pelvic lymph node (LPLN). The optimal management strategy for patients with rectal cancer with suspicious LPLN metastasis has not been determined.
Rectal cancer is the eighth most common malignancy worldwide. With the introduction of total mesorectal excision (TME) and neoadjuvant chemoradiation (NCRT), intrapelvic local control has been remarkably improved. However, lateral pelvic recurrence remains problematic, especially in patients with clinically suspicious lateral pelvic lymph node (LPLN). LPLN dissection has been applied for the management of LPLN metastasis, mainly in Japan and other Eastern countries, while the role of NCRT is more emphasized and LPLN dissection is performed in very limited cases in Western countries. However, the optimal management strategy for patients with rectal cancer with suspicious LPLN metastasis has not been determined. Herein, we review the latest studies on the optimal management of LPLN metastasis to suggest the most appropriate treatment policies according to current evidence and discuss future research directions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据